| Literature DB >> 27796187 |
Thomas Dirschka1, Girish Gupta2, Giuseppe Micali3, Eggert Stockfleth4, Nicole Basset-Séguin5, Véronique Del Marmol6, Reinhard Dummer7, Gregor B E Jemec8, Josep Malvehy9,10, Ketty Peris11, Susana Puig9,10, Alexander J Stratigos12, Iris Zalaudek13, Giovanni Pellacani14.
Abstract
Actinic keratosis (AK) is a chronic skin disease in which multiple clinical and subclinical lesions co-exist across large areas of sun-exposed skin, resulting in field cancerisation. Lesions require treatment because of their potential to transform into invasive squamous cell carcinoma. This article aims to provide office-based dermatologists and general practitioners with simple guidance on AK treatment in daily clinical practice to supplement existing evidence-based guidelines. Novel aspects of the proposed treatment algorithm include differentiating patients according to whether they have isolated scattered lesions, lesions clustered in small areas or large affected fields without reference to specific absolute numbers of lesions. Recognising that complete lesion clearance is rarely achieved in real-life practice and that AK is a chronic disease, the suggested treatment goals are to reduce the number of lesions, to achieve long-term disease control and to prevent disease progression to invasive squamous cell carcinoma. In the clinical setting, physicians should select AK treatments based on local availability, and the presentation and needs of their patients. The proposed AK treatment algorithm is easy-to-use and has high practical relevance for real-life, office-based dermatology.Entities:
Keywords: 5-fluorouracil; Diclofenac; field cancerisation; imiquimod; ingenol mebutate; photodynamic therapy
Mesh:
Substances:
Year: 2016 PMID: 27796187 DOI: 10.1080/09546634.2016.1254328
Source DB: PubMed Journal: J Dermatolog Treat ISSN: 0954-6634 Impact factor: 3.359